Patents by Inventor Sandra L. Haberichter

Sandra L. Haberichter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PLATELET TARGETED TREATMENT
    Publication number: 20190270791
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 5, 2019
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • Platelet targeted treatment
    Patent number: 10294291
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: May 21, 2019
    Assignee: PLATELET TARGETED THERAPEUTICS, LLC
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • Platelet targeted treatment
    Patent number: 9982034
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Grant
    Filed: October 24, 2013
    Date of Patent: May 29, 2018
    Assignee: PLATELET TARGETED THERAPEUTICS, LLC
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • PLATELET TARGETED TREATMENT
    Publication number: 20180009874
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Application
    Filed: August 29, 2017
    Publication date: January 11, 2018
    Inventors: David A. Wilcox, Sandra L. Haberichter
  • PLATELET TARGETED TREATMENT
    Publication number: 20150344541
    Abstract: The present disclosure relates to compositions and methods for targeting expression of exogenous genes to platelets. In particular, the present disclosure relates to treatment of hemophilia and other diseases and conditions by targeting expression of exogenous agents (e.g., clotting factors) to platelets.
    Type: Application
    Filed: October 24, 2013
    Publication date: December 3, 2015
    Inventors: David A. Wilcox, Sandra L. Haberichter